151 related articles for article (PubMed ID: 28078124)
1. Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.
Agarwal R; Sendilnathan A; Siddiqi NI; Gulati S; Ghose A; Xie C; Olowokure OO
J Gastrointest Oncol; 2016 Dec; 7(6):996-1003. PubMed ID: 28078124
[TBL] [Abstract][Full Text] [Related]
2. Long term responders to palliative chemotherapy for advanced biliary tract cancer.
Doherty MK; McNamara MG; Aneja P; McInerney E; Moignard S; Horgan AM; Jiang H; Panzarella T; Jang R; Dhani N; Hedley D; Knox JJ
J Gastrointest Oncol; 2017 Apr; 8(2):352-360. PubMed ID: 28480074
[TBL] [Abstract][Full Text] [Related]
3. Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study.
Lim SH; Hong JY; Park JO; Park YS; Kim ST
Anticancer Res; 2023 Sep; 43(9):4161-4167. PubMed ID: 37648323
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer.
Thol F; Gairing SJ; Czauderna C; Thomaidis T; Gamstätter T; Huber Y; Vollmar J; Lorenz J; Michel M; Bartsch F; Müller L; Kloeckner R; Galle PR; Wörns MA; Marquardt JU; Moehler M; Weinmann A; Foerster F
JHEP Rep; 2022 Mar; 4(3):100417. PubMed ID: 35141511
[TBL] [Abstract][Full Text] [Related]
5. Prolonged progression-free survival achieved by gemcitabine, cisplatin, and albumin-bound paclitaxel for the treatment of advanced biliary tract cancers.
Choi JH; Park H; Park JK; Lee JK; Lee KT; Lee KH
Ther Adv Med Oncol; 2024; 16():17588359231225045. PubMed ID: 38249335
[TBL] [Abstract][Full Text] [Related]
6. A population based analysis of prognostic factors in advanced biliary tract cancer.
Peixoto RD; Renouf D; Lim H
J Gastrointest Oncol; 2014 Dec; 5(6):428-32. PubMed ID: 25436121
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and capecitabine for advanced biliary cancer.
Gabriel E; Gandhi S; Attwood K; Kuvshinoff B; Hochwald S; Iyer R
J Gastrointest Oncol; 2017 Aug; 8(4):728-736. PubMed ID: 28890824
[TBL] [Abstract][Full Text] [Related]
9. Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers.
Mizrahi JD; Gunchick V; Mody K; Xiao L; Surapaneni P; Shroff RT; Sahai V
World J Gastrointest Oncol; 2020 Jan; 12(1):83-91. PubMed ID: 31966916
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC).
Heo MH; Kim HK; Lee H; Kim KM; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS; Kim ST
J Cancer; 2017; 8(8):1395-1399. PubMed ID: 28638453
[No Abstract] [Full Text] [Related]
11. Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.
Cheon J; Lee CK; Sang YB; Choi HJ; Kim MH; Ji JH; Ko KH; Kwon CI; Kim DJ; Choi SH; Kim C; Kang B; Chon HJ
Ther Adv Med Oncol; 2021; 13():17588359211035983. PubMed ID: 34394748
[TBL] [Abstract][Full Text] [Related]
12. A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada.
Beaulieu C; Lui A; Yusuf D; Abdelaziz Z; Randolph B; Batuyong E; Ghosh S; Bathe OF; Tam V; Spratlin JL
Curr Oncol; 2021 Jan; 28(1):417-427. PubMed ID: 33450805
[No Abstract] [Full Text] [Related]
13. Prognostic factors for progression-free and overall survival in advanced biliary tract cancer.
Bridgewater J; Lopes A; Wasan H; Malka D; Jensen L; Okusaka T; Knox J; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; McNamara MG; Valle JW
Ann Oncol; 2016 Jan; 27(1):134-40. PubMed ID: 26483051
[TBL] [Abstract][Full Text] [Related]
14. A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study.
Pei SN; Liao CK; Chen YS; Tseng CH; Hung CM; Chiu CC; Hsieh MC; Tsai YF; Liao HY; Liu WC; Rau KM
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359732
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis.
Ji JH; Kim YS; Park I; Lee SI; Kim RB; Park JO; Oh SY; Hwang IG; Jang JS; Song HN; Kang JH
Cancer Res Treat; 2018 Jul; 50(3):791-800. PubMed ID: 28838033
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial.
Kim ST; Oh SY; Lee J; Kang JH; Lee HW; Lee MA; Sohn BS; Hong JH; Park YS; Park JO; Lim HY
J Cancer; 2019; 10(25):6185-6190. PubMed ID: 31772650
[No Abstract] [Full Text] [Related]
17. The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy.
Salati M; Caputo F; Cunningham D; Marcheselli L; Spallanzani A; Rimini M; Gelsomino F; Reggiani-Bonetti L; Andrikou K; Rovinelli F; Smyth E; Baratelli C; Kouvelakis K; Kalaitzaki R; Gillbanks A; Michalarea V; Cascinu S; Braconi C
Eur J Cancer; 2019 Aug; 117():84-90. PubMed ID: 31276980
[TBL] [Abstract][Full Text] [Related]
18. Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials.
Lamarca A; Ross P; Wasan HS; Hubner RA; McNamara MG; Lopes A; Manoharan P; Palmer D; Bridgewater J; Valle JW
J Natl Cancer Inst; 2020 Feb; 112(2):200-210. PubMed ID: 31077311
[TBL] [Abstract][Full Text] [Related]
19. CA19-9 kinetics during systemic chemotherapy in patients with advanced or recurrent biliary tract cancer.
Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Noguchi K; Suzuki T; Nakamura T; Sato T; Ishigaki K; Hakuta R; Takeda T; Uchino R; Mizuno S; Kogure H; Tada M; Koike K
Cancer Chemother Pharmacol; 2017 Dec; 80(6):1105-1112. PubMed ID: 29038848
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prognostic factors in patients undergoing first-line chemotherapy for advanced biliary tract cancer: a retrospective analysis from a South American cancer centre.
Felismino TC; Oliveira FMA; Fogassa CAZ; Santerini SN; de Jesus VHF; Riechelmann RSP; Coimbra FJF; Mello CAL
Ecancermedicalscience; 2022; 16():1345. PubMed ID: 35242226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
